Skip to content

In the BioHarmony Drug Report Database


Deltyba (delamanid) is a small molecule pharmaceutical. Delamanid was first approved as Deltyba on 2014-04-27. It has been approved in Europe to treat multidrug-resistant tuberculosis.
Trade Name Deltyba
Common Name Delamanid
Indication multidrug-resistant tuberculosis
Drug Class Mycolic acid inhibitors
Get full access now